Pituitary tumor transforming gene binding factor: A new gene in breast cancer

Cancer Research

Volumn 70, Issue 9, 2010, Pages 3739-3749

  Watkins, Rachel J ^a   Read, Martin L ^a   Smith, Vicki E ^a   Sharma, Neil ^a   Reynolds, Gary M ^b   Buckley, Laura ^a   Doig, Craig ^c   Campbell, Moray J ^c   Lewy, Greg ^a   Eggo, Margaret C ^a   Loubiere, Laurence S ^a   Franklyn, Jayne A ^a   Boelaert, Kristien ^a   McCabe, Christopher J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b University of Birmingham   (United Kingdom)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN; ESTROGEN BINDING PROTEIN; ESTROGEN RECEPTOR ALPHA; MATRIGEL; MESSENGER RNA; OLIGONUCLEOTIDE; PITUITARY TUMOR TRANSFORMING GENE BINDING FACTOR; SECURIN; SMALL INTERFERING RNA; TRANSFORMING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST; BREAST CANCER; CELL ASSAY; CELL INVASION; CELL STRAIN MCF 7; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ESTROGEN BINDING; ESTROGEN RESPONSIVE ELEMENT; GENE CONTROL; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE REPEAT; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN SECRETION; RNA TRANSLATION;

ADENOCARCINOMA; BREAST NEOPLASMS; CELL LINE, TUMOR; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS; RNA, MESSENGER;

EID: 77951709199     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-3531     Document Type: Article

References (27)

1. Allred DC, Medina D. The relevance of mouse models to understanding the development and progression of human breast cancer. J Mammary Gland Biol Neoplasia 2008;13:279-288
2. Boelaert K, Tannahill LA, Bulmer JN, et al. A potential role for PTTG/ securin in the developing human fetal brain. FASEB J 2003;17:1631-1639
3. Boelaert K, Smith VE, Stratford AL, et al. PTTG and PBF repress the human sodium iodide symporter. Oncogene 2007;26:4344-4356 (Pubitemid 47014460)
4. Chien W, Pei L. A novel binding factor facilitates nuclear translocation and transcriptional activation function of the pituitary tumor-transforming gene product. J Biol Chem 2000;275:19422-19427 (Pubitemid 30422919)
5. Mo Z, Zu X, Xie Z, et al. Antitumor effect of F-PBF(β-TrCP)-induced targeted PTTG1 degradation in HeLa cells. J Biotechnol 2009;139: 6-11.
6. Smith VE, Read ML, Turnell AS, et al. A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer. J Cell Sci 2009;122:3393-3402
7. Stock M, Schafer H, Fliegauf M, Otto F. Identification of novel genes of the bone-specific transcription factor Runx2. J Bone Miner Res 2004;19:959-972 (Pubitemid 41103453)
8. Stratford AL, Boelaert K, Tannahill LA, et al. Pituitary tumor transforming gene binding factor: a novel transforming gene in thyroid tumorigenesis. J Clin Endocrinol Metab 2005;90:4341-4349 (Pubitemid 41058217)
9. Tfelt-Hansen J, Yano S, Bandyopadhyay S, Carroll R, Brown EM, Chattopadhyay N. Expression of pituitary tumor transforming gene (PTTG) and its binding protein in human astrocytes and astrocytoma cells: function and regulation of PTTG in U87 astrocytoma cells. Endocrinology 2004;145:4222-4231 (Pubitemid 39120571)
10. Yaspo ML, Aaltonen J, Horelli-Kuitunen N, Peltonen L, Lehrach H. Cloning of a novel human putative type Ia integral membrane protein mapping to 21q22.3. Genomics 1998;49:133-136 (Pubitemid 28194446)
11. Pei L, Melmed S. Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 1997;11:433-441 (Pubitemid 27147011)
12. Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 1999;5:1317-1321 (Pubitemid 29535612)
13. Heaney AP, Fernando M, Melmed S. Functional role of estrogen in pituitary tumor pathogenesis. J Clin Invest 2002;109:277-283 (Pubitemid 34083748)
14. Ogbagabriel S, Fernando M, Waldman FM, Bose S, Heaney AP. Securin is overexpressed in breast cancer. Mod Pathol 2005;18: 985-990
15. Chen L, Puri R, Lefkowitz EJ, Kakar SS. Identification of the human pituitary tumor transforming gene (hPTTG) family: molecular structure, expression, and chromosomal localization. Gene 2000;248: 41-50. (Pubitemid 30259200)
16. Murray PG, Lissauer D, Junying J, et al. Reactivity with A monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome. Cancer Res 2003;63:2338-2343
17. Kim D, Pemberton H, Stratford AL, et al. Pituitary tumour transforming gene (PTTG) induces genetic instability in thyroid cells. Oncogene 2005;24:4861-4866
18. Kim DS, Franklyn JA, Stratford AL, et al. Pituitary tumor-transforming gene regulates multiple downstream angiogenic genes in thyroid cancer. J Clin Endocrinol Metab 2006;91:1119-1128
19. Kim DS, Franklyn JA, Smith VE, et al. Securin induces genetic instability in colorectal cancer by inhibiting double-stranded DNA repair activity. Carcinogenesis 2007;28:749-759
20. Simmonds MJ, Heward JM, Carr-Smith J, Foxall H, Franklyn JA, Gough SC. Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease. J Clin Endocrinol Metab 2006;91:1056-1061
21. Liu Y, Asch H, Kulesz-Martin MF. Functional quantification of DNA-binding proteins p53 and estrogen receptor in cells and tumor tissues by DNA affinity immunoblotting. Cancer Res 2001;61:5402-5406
22. Vyhlidal C, Samudio I, Kladde MP, Safe S. Transcriptional activation of transforming growth factor α by estradiol: requirement for both a GC-rich site and an estrogen response element half-site. J Mol Endocrinol 2000;24:329-338
23. James SR, Franklyn JA, Reaves BJ, et al. Monocarboxylate transporter 8 (MCT8) in neuronal cell growth. Endocrinology 2008.
24. Taupenot L, Harper KL, Mahapatra NR, Parmer RJ, Mahata SK, O'Connor DT. Identification of a novel sorting determinant for the regulated pathway in the secretory protein chromogranin A. J Cell Sci 2002;115:4827-4841
25. Jacobs DT, Weigert R, Grode KD, Donaldson JG, Cheney RE. Myosin Vc is a molecular motor that functions in secretory granule trafficking. Mol Biol Cell 2009;20:4471-4488
26. Brooks SC, Skafar DF. From ligand structure to biological activity: modified estratrienes and their estrogenic and antiestrogenic effects in MCF-7 cells. Steroids 2004;69:401-418
27. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 2000;148:779-790